Guidance

Importing medicines from the EEA after Brexit

If you import human medicines from the EU, Norway, Iceland or Liechtenstein, you’ll need to review your wholesale dealer’s licence if there’s a no-deal Brexit.

Documents

Details

Stay up to date

The UK is leaving the EU. This page tells you how to prepare for Brexit and will be updated if anything changes.

Sign up for email alerts to get the latest information.

In a no-deal Brexit existing wholesale dealers that source human medicines from an EEA State for use in the UK will need to review their existing wholesale dealer’s licence.

This guidance will apply from exit day in line with the Human Medicines Regulations (Amendment etc.) (EU Exit) Regulations 2019.

Published 11 March 2019
Last updated 9 October 2019 + show all updates
  1. Change of text within Stay up to date box.
  2. Updated page titles and the summary to clarify that this guidance is about importing medicines from EEA countries if there's a no-deal Brexit. The rest of the content has not changed.
  3. First published.